Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05286151
Other study ID # HUM00196133
Secondary ID 2R01DC011277
Status Recruiting
Phase N/A
First received
Last updated
Start date July 23, 2022
Est. completion date January 2026

Study information

Verified date June 2024
Source University of Michigan
Contact Soo-Eun Chang, PhD
Phone 734-232-0300
Email sooeunc@umich.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The specific purpose of this clinical trial is to compare performance on rhythm perception and production tasks between children who stutter and children who do not stutter. The overall project also aims to investigate how performance on rhythm tasks may be related to brain activity (non-clinical trial).


Description:

Participants in the clinical trial portion of this study will complete rhythm discrimination and finger tapping experiments once a year for 3 years. The study team will compare performance between groups. Participants will also participate in the non-trial portion of the project that includes having magnetic resonance imaging (MRI) each year for 3 years.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date January 2026
Est. primary completion date January 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 9 Years to 13 Years
Eligibility Inclusion Criteria Children who stutter: - English as primary language - Current or past stuttering diagnosis Inclusion Criteria Children who do not stutter: - English as primary language Exclusion Criteria Children who stutter: - Diagnosed/under treatment for any neurological or psychiatric conditions - Head trauma with loss of consciousness - Major medical illness - Hearing loss- Language/motor delay (below -2 standard deviations on standardized assessments) - Face, motor, or reflex abnormalities Exclusion Criteria Children who do not stutter: - Personal or family history of stuttering - Diagnosed/under treatment for any neurological or psychiatric conditions - Head trauma with loss of consciousness - Major medical illness - Hearing loss - Language/motor delay (below -2 standard deviations on standardized assessments - Face, motor, or reflex abnormalities

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Rhythm discrimination
Participants will complete a rhythm discrimination task once per year for 3 years.

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan National Institute on Deafness and Other Communication Disorders (NIDCD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rhythm discrimination (d') Performance on the rhythm discrimination task will be assessed using a signal detection analysis to distinguish between participants' ability to discriminate same and different rhythms from any general tendency to respond same or different. Hit rates (HRs) and false alarm rates (FARs) will be obtained to calculate d' (a measure of sensitivity; determined by z(HR) - z(FAR)). Year 1
Primary Rhythm discrimination (d') Performance on the rhythm discrimination task will be assessed using a signal detection analysis to distinguish between participants' ability to discriminate same and different rhythms from any general tendency to respond same or different. Hit rates (HRs) and false alarm rates (FARs) will be obtained to calculate d' (a measure of sensitivity; determined by z(HR) - z(FAR)). Year 2
Primary Rhythm discrimination (d') Performance on the rhythm discrimination task will be assessed using a signal detection analysis to distinguish between participants' ability to discriminate same and different rhythms from any general tendency to respond same or different. Hit rates (HRs) and false alarm rates (FARs) will be obtained to calculate d' (a measure of sensitivity; determined by z(HR) - z(FAR)). Year 3
See also
  Status Clinical Trial Phase
Suspended NCT01684657 - A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering Phase 3
Not yet recruiting NCT05437627 - Computerized Based Analysis for Detection and Severity Assessment of Stuttering
Completed NCT02288598 - Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering N/A
Completed NCT00001602 - Genetic Factors Related to Stuttering N/A
Active, not recruiting NCT04082104 - Assessment of Stuttering Severity in Adults and Adolescences in Conversational and Narrative Contexts
Completed NCT04580966 - IBSR Intervention for Adults Who Stutter N/A
Recruiting NCT00148161 - Activity of the Auditory Cortex During Speech Perception and Speech Production in Stuttering N/A
Recruiting NCT05908123 - Exploring the Nature, Assessment and Treatment of Stuttering N/A
Completed NCT00001551 - Characteristics of Idiopathic Familial Speech Disorders N/A
Withdrawn NCT01315730 - The Effects of Tactile Speech Feedback on Stuttering Frequency Phase 1
Completed NCT00004991 - Study of Brain Activity During Speech Production and Speech Perception N/A
Completed NCT00001604 - Genetic Linkage Studies of Stuttering
Recruiting NCT00680303 - Spacing Lidcombe Program Clinic Visits Phase 2
Recruiting NCT00709072 - Follow-up of Children After Stuttering Treatment Phase 2
Completed NCT00830154 - A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering Phase 2/Phase 3
Completed NCT03698539 - How Stuttering and Gestures Influence the Intelligibility of Individuals With Down Syndrome
Completed NCT04505696 - Providing Speech Therapy Awareness in Private Schools N/A
Recruiting NCT04929184 - Speech Processing in Stuttering N/A
Terminated NCT00001308 - Central Mechanisms in Speech Motor Control Studied With H215O PET
Completed NCT01097161 - Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program N/A